Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context. Braz. J. Pharm. Sci. [Internet]. 2012 Jun. 1 [cited 2024 May 21];48(2):227-36. Available from: https://revistas.usp.br/bjps/article/view/46173